Bunschoten Anton, van Willigen Danny M, Buckle Tessa, van den Berg Nynke S, Welling Mick M, Spa Silvia J, Wester Hans-Jürgen, van Leeuwen Fijs W B
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center , Albinusdreef 2, PO BOX 9600, 2300 RC, Leiden, The Netherlands.
Departments of Urology and Head and Neck Surgery & Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Bioconjug Chem. 2016 May 18;27(5):1253-8. doi: 10.1021/acs.bioconjchem.6b00093. Epub 2016 Apr 28.
Quantitative assessment of affinity and kinetics is a critical component in the development of (receptor-targeted) radiotracers. For fluorescent tracers, such an assessment is currently not yet applied, while (small) changes in chemical composition of the fluorescent component might have substantial influence on the overall properties of a fluorescent tracer. Hybrid imaging labels that contain both a radiolabel and a fluorescent dye can be used to evaluate both the affinity (fluorescent label) and the in vivo distribution (radiolabel) of a targeted tracer. We present a hybrid label oriented and matrix-based scoring approach that enabled quantitative assessment of the influence of (overall) charge and lipophilicity of the fluorescent label on the (in vivo) characteristics of αvβ3-integrin targeted tracers. Systematic chemical alterations in the fluorescent dye were shown to result in a clear difference in the in vivo distribution of the different hybrid tracers. The applied evaluation technique resulted in an optimized targeted tracer for αvβ3-integrin, which combined the highest T/M ratio with the lowest uptake in other organs. Obviously this selection concept would also be applicable during the development of other (receptor-targeted) imaging tracers.
亲和力和动力学的定量评估是(受体靶向)放射性示踪剂研发中的关键组成部分。对于荧光示踪剂,目前尚未进行此类评估,而荧光成分化学组成的(微小)变化可能会对荧光示踪剂的整体性质产生重大影响。同时包含放射性标记和荧光染料的混合成像标记物可用于评估靶向示踪剂的亲和力(荧光标记)和体内分布(放射性标记)。我们提出了一种基于混合标记物导向和矩阵的评分方法,该方法能够定量评估荧光标记物的(整体)电荷和亲脂性对αvβ3整合素靶向示踪剂的(体内)特性的影响。荧光染料的系统性化学改变导致不同混合示踪剂在体内分布出现明显差异。所应用的评估技术产生了一种针对αvβ3整合素的优化靶向示踪剂,其具有最高的T/M比和其他器官中最低的摄取量。显然,这种选择概念在其他(受体靶向)成像示踪剂的研发过程中也将适用。